ketoconazole has been researched along with Anorexia in 4 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group." | 7.66 | Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. ( Bowles, C; Cloud, G; Craven, PC; Dismukes, WE; Fields, BT; Gallis, HA; Graybill, JR; Gregg, CR; Kaplowitz, LG; Kerkering, TA; Marier, RL; Medoff, G; Sarosi, GA; Shadomy, S; Stamm, AM; Stevens, DA; Stiller, RL, 1983) |
| "The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group." | 3.66 | Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. ( Bowles, C; Cloud, G; Craven, PC; Dismukes, WE; Fields, BT; Gallis, HA; Graybill, JR; Gregg, CR; Kaplowitz, LG; Kerkering, TA; Marier, RL; Medoff, G; Sarosi, GA; Shadomy, S; Stamm, AM; Stevens, DA; Stiller, RL, 1983) |
| " One additional cat failed to improve initially, but complete resolution was achieved after the dosage of ketoconazole was doubled." | 1.28 | Ketoconazole for treatment of dermatophytosis in cats. ( Chalmers, SA; Medleau, L, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dismukes, WE | 1 |
| Stamm, AM | 1 |
| Graybill, JR | 1 |
| Craven, PC | 1 |
| Stevens, DA | 1 |
| Stiller, RL | 1 |
| Sarosi, GA | 1 |
| Medoff, G | 1 |
| Gregg, CR | 1 |
| Gallis, HA | 1 |
| Fields, BT | 1 |
| Marier, RL | 1 |
| Kerkering, TA | 1 |
| Kaplowitz, LG | 1 |
| Cloud, G | 1 |
| Bowles, C | 1 |
| Shadomy, S | 1 |
| García, ME | 1 |
| Caballero, J | 1 |
| Toni, P | 1 |
| Garcia, I | 1 |
| Martinez de Merlo, E | 1 |
| Rollan, E | 1 |
| Gonzalez, M | 1 |
| Blanco, JL | 1 |
| Medleau, L | 1 |
| Chalmers, SA | 1 |
4 other studies available for ketoconazole and Anorexia
| Article | Year |
|---|---|
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Child; Child, Preschool; Drug Evaluation; Huma | 1983 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
Disseminated mycoses in a dog by Paecilomyces sp.
Topics: Animals; Anorexia; Antifungal Agents; Aorta, Abdominal; Depression; Dog Diseases; Dogs; Fatal Outcom | 2000 |
Ketoconazole for treatment of dermatophytosis in cats.
Topics: Animals; Anorexia; Cat Diseases; Cats; Dermatomycoses; Diarrhea; Female; Ketoconazole; Male; Vomitin | 1992 |